Increase in cancer screening may be result of ACA provision
the ONA take:
According to a new study published online in the journal Cancer, researchers from the American Cancer Society have found that colorectal cancer screening increased in individuals of lower socioeconomic status after 2008, potentially as a result of a provision in the Affordable Care Act that removed financial barriers to preventive services, including breast and colorectal cancer screening.
For the study, researchers analyzed data from the National Health Interview Survey to compare breast cancer and colorectal cancer screening prevalence among individuals with private and Medicare insurance by socioeconomic status before and after the Affordable Care Act was enacted.
Results showed that colorectal cancer screening increased from 57.3% to 61.2% between 2008 and 2013. The increase in screening prevalence was apparent in least-educated, low-income, and Medicare-insured patients, but not among those in higher socioeconomic groups.
The researchers also found a significant increase in colorectal cancer screening among Medicare-insured and privately insured individuals across all socioeconomic levels.
There was no increase in breast cancer screening between 2008 and 2013, possibly due to fewer barriers because of lower cost, women's health initiatives, and the already higher prevalence of breast cancer screening prevalence compared with colorectal cancer screening.
Affordable Care Act has removed financial barriers to preventive services, including breast and colorectal cancer screening.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|